PHASE-I RADIOIMMUNOTHERAPY TRIAL EVALUATING (90)YTTRIUM LABELED ANTI-CEA CHIMERIC T84.66 IN PATIENTS WITH METASTATIC CEA-PRODUCING MALIGNANCIES

Citation
J. Wong et al., PHASE-I RADIOIMMUNOTHERAPY TRIAL EVALUATING (90)YTTRIUM LABELED ANTI-CEA CHIMERIC T84.66 IN PATIENTS WITH METASTATIC CEA-PRODUCING MALIGNANCIES, International journal of radiation oncology, biology, physics, 39(2), 1997, pp. 205-205
Citations number
NO
Categorie Soggetti
Oncology,"Radiology,Nuclear Medicine & Medical Imaging
ISSN journal
03603016
Volume
39
Issue
2
Year of publication
1997
Supplement
S
Pages
205 - 205
Database
ISI
SICI code
0360-3016(1997)39:2<205:PRTE(L>2.0.ZU;2-4